Health

The Conference Forum Launches 1st Dedicated Biotech Chief Medical Officer Newsletter

Leave a comment


Inaugural Issue of the Chief Medical Officer 360º Newsletter

CMOs are first and foremost responsible for patient safety and drive all R&D functions while supporting the CEO. We want to build more resources to help the CMO community interact and share peer-to-peer best practices.


NEW YORK (PRWEB)

The Conference Forum is pleased to announce the launch of Chief Medical Officer 360°, the first newsletter solely dedicated to the unique role of the Chief Medical Officer in the biotech industry. The newsletter will capture a wide range of perspectives on the responsibilities, problem-solving, best practices and career development of CMOs and Heads of R&D from different therapeutic areas in the US and around the world. Physician scientists and others serving in biotech will also benefit from the expertise of leaders in the community.

“Chief Medical Officers are responsible for a vast number of R&D functions and we are excited to publish a quarterly newsletter specifically for this community,” said Andrew Goldstein, Editor of Chief Medical Officer 360°.

The inaugural issue will feature the following topics: the evolving role of the CMO through IPO; incorporating the patient perspective; enterprise management; developing treatments for SARS-CoV-2; advice for R&D leaders in challenging times; and partnering effectively with CROs. The issue ends with a recap from the archive: a session from the 2017 Chief Medical Officer Summit on How R&D Leadership Can Work More Collaboratively with Investors.

“CMOs are first and foremost responsible for patient safety and drive all R&D functions while supporting the CEO. We want to build more resources to help the CMO community interact and share peer-to-peer best practices,” said Valerie Bowling, Executive Director, the Conference Forum.

The following CMOs are featured in the inaugural issue: Dr Dana Hilt, CMO, Frequency Therapeutics, Dr Barry Ticho, CMO, Stoke Therapeutics, Dr Nerissa Kreher, CMO, Tiburio Therapeutics, Dr Beth Trehu, CMO, Jounce Therapeutics, Dr Akshay Vaishnaw, President, R&D, Alnylam, Dr Francisco Diaz-Mitoma, CMO, VBI Vaccines, and Dr Daniel Burch, Global Head, PPD Biotech.

The Conference Forum also presents the Chief Medical Officer Summit 360° two-day event and CMO-related podcasts. With the conferences, podcasts and quarterly newsletters, the company provides helpful insights and ongoing support for the CMO and R&D leadership community.

About the Conference Forum:

The Conference Forum is a research firm and develops specialized content for professionals in the life science and healthcare industries. The company currently offers conferences and newsletters for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange of ideas and provide quality networking to help move therapeutics to patients faster. Learn more about The Conference Forum at https://theconferenceforum.org.

Share article on social media or email:

Leave a Reply